Johnson & Johnson Cv Rx, Inc. Transaction History
Johnson & Johnson
- $301 Million
- Q1 2025
A detailed history of Johnson & Johnson transactions in Cv Rx, Inc. stock. As of the latest transaction made, Johnson & Johnson holds 4,103,430 shares of CVRX stock, worth $26.8 Million. This represents 16.67% of its overall portfolio holdings.
Number of Shares
4,103,430
Previous 4,103,430
-0.0%
Holding current value
$26.8 Million
Previous $52 Million
3.47%
% of portfolio
16.67%
Previous 17.73%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
99Shares Held
16.3MCall Options Held
53.4KPut Options Held
32.3K-
Nea Management Company, LLC Timonium, MD2.03MShares$13.2 Million2.35% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT1.23MShares$8.02 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$6.56 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$5.71 Million0.0% of portfolio
-
Emerald Advisers, LLC591KShares$3.85 Million0.36% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $134M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...